Consultant, Medical Oncology
MBBS, MD (NYU), Fellow (Heme&MedOnc USA), MS (Columbia Univ, USA) Diplomate American Board – Internal Medicine, Hematology and Medical Oncology
All of Solid Tumors including Head and Neck, Lung, Breast, Sarcomas, Gastrointestinal, Genitourinary and Gynecological Cancers, Cancer Genomics, Chemotherapy, Targeted Therapy and Immunotherapy
Dr. Sewanti Limaye comes to Kokilaben Dhirubhai Ambani Hospital from Columbia University Medical Center/New York Presbyterian Hospital, New York-USA where she worked as an Attending in Medical Oncology and Assistant Professor of Medicine. She specializes in the treatment of all Solid Tumors including Breast, Lung, Head and Neck, GI, GU and Gyn Cancers. In addition to giving chemotherapy, she has specific expertise in Cancer Genomics, Targeted Therapy and cutting edge treatment with Immunotherapy. Dr. Limaye is board certified in Internal Medicine, Hematology and Medical Oncology and has been practising as a Medical Oncologist since the year 2009.
Dr. Limaye received her medical degree with honors from Jawahar Lal Nehru Medical College, Bhagalpur and did her residency in Internal Medicine from NY Downtown Hospital - New York University. She did her fellowship in Hematology and Medical Oncology from Albert Einstein University, North Shore- Long Island Jewish Medical Center, New York. She was nominated to serve as the Chief Fellow in the final year of her fellowship. After completing her fellowship, Dr. Limaye went on to work as an Attending in Medical Oncology at the Dana Farber Cancer Institute/Brigham and Women's Hospital and at the Phase I - Early Drug Development Center - Harvard Medical School in Boston, USA. She also did a Masters in Patient Oriented Research (Cancer Genomics and Biostatistics) from Mailman School of Public Health, Columbia University, New York. Most recently, she worked as an Attending at Columbia University Medical Center in the Medical Oncology division where she practised cancer genomics, chemotherapy, targeted therapy and cutting edge treatment with immunotherapy.
Dr. Limaye has been involved in research with leaders at Memorial Sloan Kettering Cancer Center, Dana Farber Cancer Institute, Columbia University Medical Center and National Cancer Institute, USA. She has led several national and international trials and has been a part of Data Safety Monitoring Boards.
Dr. Limaye is committed to the development of novel therapeutics in Solid Tumors.